General Information of the Compound
| Compound ID |
CP0021175
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1,11-dihydro-1,3,5,11-tetraaza-benzo[a]trindene-4,6-dione
Show/Hide
|
||||||||||||||||||
| Synonyms |
1,11-dihydro-1,3,5,11-tetraaza-benzo[a]trindene-4,6-dione
1H-Imidazo[4,5-a]pyrrolo[3,4-c]carbazole-4,6(5H,11H)-dione
219828-99-6
3,11-Dihydro-1,3,5,11-tetraaza-benzo[a]trindene-4,6-dione
BDBM50216165
CHEMBL240747
CTK1A7209
DTXSID90415922
GRANULATIMIDE
SCHEMBL4238896
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H8N4O2
|
||||||||||||||||||
| Molecular Weight |
276.255
|
||||||||||||||||||
| Canonical SMILES |
O=C1NC(=O)c2c1c1[nH]cnc1c1[nH]c3ccccc3c21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H8N4O2/c20-14-9-8-6-3-1-2-4-7(6)18-12(8)13-11(16-5-17-13)10(9)15(21)19-14/h1-5,18H,(H,16,17)(H,19,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LBTREMHIJGMYQN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound